Scarica l'app Stockscreener
0.5618
2.15%
0.0118
Precedente Chiudi:
$0.55
Aprire:
$0.5732
Volume 24 ore:
782.91K
Relative Volume:
0.83
Capitalizzazione di mercato:
$48.40M
Reddito:
$2.24M
Utile/perdita netta:
$-136.67M
Rapporto P/E:
-0.2453
EPS:
-2.29
Flusso di cassa netto:
$-102.08M
1 W Prestazione:
+10.74%
1M Prestazione:
-2.87%
6M Prestazione:
-27.46%
1 anno Prestazione:
-66.16%
Intervallo 1D:
$0.55
$0.5799
Intervallo di 1 settimana:
$0.48
$0.5799
Portata 52W:
$0.3418
$2.05
Century Therapeutics Inc Stock (IPSC) Company Profile
Nome
Century Therapeutics Inc
Settore
Industria
Telefono
215-981-4000
Indirizzo
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Confronta IPSC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IPSC
Century Therapeutics Inc
|
0.5618 | 47.39M | 2.24M | -136.67M | -102.08M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-08 | Iniziato | Rodman & Renshaw | Buy |
| 2023-08-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-27 | Iniziato | Chardan Capital Markets | Buy |
| 2022-10-31 | Iniziato | Guggenheim | Buy |
| 2022-10-10 | Iniziato | Canaccord Genuity | Buy |
| 2022-05-23 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-12 | Iniziato | William Blair | Mkt Perform |
| 2021-07-13 | Iniziato | BofA Securities | Buy |
| 2021-07-13 | Iniziato | JP Morgan | Overweight |
| 2021-07-13 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Century Therapeutics Inc Borsa (IPSC) Ultime notizie
Is it too late to sell Century Therapeutics Inc.IPO Watch & Daily Profit Maximizing Tips - Newser
Is Century Therapeutics Inc. showing insider buyingDividend Hike & AI Forecasted Stock Moves - mustnews.co.kr
How hedge fund analytics apply to Century Therapeutics Inc. stock2025 Market Overview & Fast Moving Stock Watchlists - Newser
IPSC long term stock - AInvest
Technical analysis overview for Century Therapeutics Inc. stockJuly 2025 Short Interest & Low Risk High Win Rate Picks - Newser
Century Therapeutics to Present Preclinical Data at EULAR 2025 Congress - MSN
What earnings revisions data tells us about Century Therapeutics Inc.Quarterly Profit Report & AI Based Buy and Sell Signals - Newser
Century Therapeutics (NASDAQ:IPSC) Lowered to “Sell” Rating by Wall Street Zen - Defense World
What institutions are buying Century Therapeutics Inc. stock nowWeekly Stock Analysis & Weekly Setup with High ROI Potential - Newser
Century Therapeutics 2025 Q1 Earnings Record Net Income Surges 372.8% - AInvest
Century Therapeutics Reports Q2 2025 Financials and Updates - TipRanks
Can Century Therapeutics Inc. expand its profit marginsJuly 2025 Review & Smart Swing Trading Alerts - newsyoung.net
Century Therapeutics shares fall 1.82% after-hours as patient dosing continues in CALiPSO-1 trial. - AInvest
Century Therapeutics (IPSC): Assessing the Value of Persistent Earnings Losses Amid Promising Pipeline Catalysts - AInvest
Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Century Therapeutics pushes novel cell therapy into clinical trials, extends cash runway to 2027 - Stock Titan
Earnings visualization tools for Century Therapeutics Inc.July 2025 Fed Impact & AI Optimized Trading Strategy Guides - Newser
Century Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern Forming2025 Fundamental Recap & Real-Time Market Sentiment Alerts - Newser
Century Therapeutics Inc. Recovery Likely Here’s What Data ShowsExit Ready Momentum Stock Watchlist Expanded - 선데이타임즈
Backtesting results for Century Therapeutics Inc. trading strategiesLong-Term Safety Investment Analysis Report - Newser
Measuring Century Therapeutics Inc.’s beta against major indicesPortfolio Review Summary with Five-Year Outlook - Newser
Philly’s biotech industry keeps losing local jobs in a volatile market - WHYY
Is Century Therapeutics Inc. showing signs of accumulationTrade Setup Builder with Custom Alerts - Newser
Layoff Tracker: Bicycle, Tune, Iovance, Precision Downsize to Conserve Cash - BioSpace
How Century Therapeutics Inc. stock performs during market volatilityStock Trading Session Highlights and Summary - Newser
Century Therapeutics (IPSC) to Release Quarterly Earnings on Thursday - Defense World
Breakout Traders Target Century Therapeutics Inc. on Recovery SetupVerified Signal From Chart Patterns Detected - beatles.ru
How does Century Therapeutics Inc. compare to its industry peersMaximize portfolio growth with expert advice - Jammu Links News
Century Therapeutics Inc. Stock Analysis and ForecastGet expert advice on portfolio optimization - Jammu Links News
Is Century Therapeutics Inc. a good long term investmentSkyrocketing returns - Jammu Links News
What catalysts could drive Century Therapeutics Inc. stock higher in 2025Build wealth faster with high-performing stocks - Jammu Links News
What are the technical indicators suggesting about Century Therapeutics Inc.Achieve exceptional returns with expert guidance - Jammu Links News
What are the latest earnings results for Century Therapeutics Inc.Capitalize on market trends before they peak - Jammu Links News
Century Therapeutics Inc Azioni (IPSC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):